Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests

After surgery, radiotherapy, chemotherapy, 80 visits to oncologists and more than 300 hours in clinics, Stephanie Butland decided she had had enough cancer treatment for one lifetime.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.